Bylvay Capsule, Coated Pellets
Product Images NDC 15054-3301

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Bylvay (NDC 15054-3301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipsen Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bylvay 01)

FDA Label Image

Figure 1 (Bylvay 02)

This is a Scratching Score evaluation showing the scores from different treatments: Placebo, Odevixibat 40 mcg/kg/day, and Odevixibat 120 mcg/kg/day. The scores are listed at 40, 15, and 10 respectively over the course of a month.*

FDA Label Image

Figure 2 (Bylvay 03)

This text appears to be a table showing a "Scratching Score" comparison between a placebo and a substance called "Odevixibat" at a dosage of 120 µg/kg/day over the course of a month. The scores are indicated as 40 for placebo and 35 for Odevixibat, with sub-scores of 05 and 0.0.*

FDA Label Image

Figure A (Bylvay 04)

FDA Label Image

Figure B (Bylvay 05)

FDA Label Image

Figure C (Bylvay 06)

FDA Label Image

Figure D (Bylvay 07)

FDA Label Image

Figure E (Bylvay 08)

FDA Label Image

Figure F (Bylvay 09)

FDA Label Image

Figure G (Bylvay 10)

FDA Label Image

Principal Display Panel (200 mcg Capsule Bottle Carton)

This is a description of a medication named Odevixibat in the form of oral pellets, contained in capsules with each capsule containing 200 mg of Odevixibat. The medication is distributed by Ipsen Biopharmaceuticals, Inc. and is manufactured in India. It is a prescription-only medication recommended to be stored between 20°C to 25°C (68°F to 77°F) and can have excursions permitted between 15°C and 30°C (59°F and 86°F). For more information on usage and dosage, it is advised to refer to the prescribing information provided.*

FDA Label Image

Principal Display Panel (400 mcg Capsule Bottle Carton)

This is a description of a medication called Bylvay consisting of capsules with 400 mcg of odevixibat. It is recommended to store the capsules between 20°C to 25°C (66°F to 77°F). The medication is distributed by Ipsen Biopharmaceuticals, Inc. and the manufacturing origin is India. For dosage information, refer to the prescribing information provided. The copyright for this product is held by Ipsen Biopharmaceuticals Inc.*

FDA Label Image

Principal Display Panel (600 mcg Capsule Bottle Carton)

FDA Label Image

Principal Display Panel (1,200 mcg Capsule Bottle Carton)

This is the product information for X Bylvay, a medication containing 1,200 mg of odevixil per capsule. The manufacturer is Ipsen Biopharmaceuticals Inc. from Cambridge, MA. The recommended storage temperature is between 20°C to 25°C with excursions permitted between 15°C and 30°C. Please refer to the prescribing information for recommended dosage.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.